Drug FDA Class I Ongoing Mislabeling

SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China

ANTHONY TRINH, 123Herbals LLC Published Mar 11, 2026

Risk level

Class I

Dangerous or defective — could cause serious health problems or death.

Severity score 85/100

What should you do?

Check whether you have this product, using the lot codes, UPCs, and dates listed below.
Do not eat, serve, or sell the affected product.
Return it to the place of purchase for a refund, or throw it away in a sealed bag so people and animals can’t get to it.
Contact ANTHONY TRINH, 123Herbals LLC or your place of purchase with questions, and see the source record below for full details.

Reason for recall

Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.

Hazards

Undeclared meloxicam · primary

Affected products (1)

SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China

N/A

Lot codes: within

Code info: All lots within expiry

Affected areas

Nationwide

Timeline

Initiated

Oct 20, 2025
Published

Mar 11, 2026

Recall number: D-0388-2026
Agency: U.S. Food and Drug Administration
Country: US

Source data (openFDA JSON) About FDA enforcement reports

FDA records come from the openFDA drug enforcement-report dataset — the agency's full weekly enforcement list. Most entries are not issued as consumer press releases, so they won't appear on fda.gov/recalls or in a web search. The source record link above resolves this exact recall by its number.